|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 90.25 INR | +5.83% |
|
+8.01% | -10.33% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Medicinal Chemicals and Botanical Products | ||||||||||
Pharmaceuticals | 230.67Cr | 394.61Cr | 354.32Cr | 381.76Cr | 405.51Cr | |||||
Total Assets | 371.14Cr | 427.78Cr | 513.96Cr | 566.42Cr | 588.03Cr | |||||
Interest Expense | -11Cr | -6.54Cr | -7.99Cr | -7.63Cr | -8.49Cr | |||||
Income Tax Expense | 5.63Cr | 22Cr | 16Cr | 9.92Cr | 9.84Cr | |||||
CAPEX | -18Cr | -21Cr | -29Cr | -18Cr | -15Cr | |||||
EBT | 41Cr | 95Cr | 73Cr | 53Cr | 40Cr | |||||
D&A | 8.55Cr | 9.48Cr | 10Cr | 12Cr | 9.93Cr | |||||
Net Income | 36Cr | 73Cr | 57Cr | 44Cr | 30Cr |
Geographical Revenue Distribution History
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
India | 129.84Cr | 201.02Cr | 203.13Cr | 269.48Cr | 327.64Cr | |||||
Outside India | 99Cr | 190.33Cr | 141.32Cr | 107.15Cr | 72Cr |
- Stock Market
- Equities
- THEMISMED Stock
- Financials Themis Medicare Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















